Skip to main content
Decorative image of the COVID-19 Learning Lounge

Use Of Electronic Clinical Data To Track Incidence And Mortality For Sars-cov-2-associated Sepsis

SUMMARY

Efforts to quantify the burden of SARS-CoV-2–associated sepsis have been limited by inconsistent definitions and underrecognition of viral sepsis. An original cohort investigation was conducted to track incidence of SARS-CoV-2–associated sepsis using electronic health record (EHR)-based algorithms. Data accessed from five Massachusetts hospitals between March 2020 and November 2022 suggests that the virus responsible for COVID-19 was a more common and life-threatening cause of sepsis than presumed bacterial-associated sepsis early in the pandemic. These findings highlight the high burden of SARS-CoV-2–associated sepsis and demonstrate the utility of EHR-based algorithms to conduct surveillance for viral and bacterial sepsis.

FEATURED EXPERT    

Claire N. Shappell, MD, MPH, Division of Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital; Department of Population Medicine, Harvard Medical School, Boston, MA

Michael Klompas, MD, MPH, Division of Infectious Diseases, Brigham and Women’s Hospital; Department of Population Medicine, Harvard Medical School, Boston, MA

Christina Chan, MPH, Department of Population Medicine, Harvard Medical School, Boston, MA


GET STARTED

Access the Original Investigation on JAMA Network

Estimated reading time: 22 minutes


We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.


Global Solutions

Sepsis

When time is critical, you need accurate information, and you need it fast. bioMérieux is your partner along the sepsis management pathway, offering the most comprehensive solution for sepsis diagnostics to optimize antibiotic therapy for better patient care.

U.S. bioMérieux Solutions

US Solutions

Sepsis

bioMérieux supports the continuum of sepsis care with diagnostic solutions that span the entire treatment workflow. 

PUBLISHED BY

JAMA Network Open
September 29, 2023


SHARE THIS ARTICLE: